News & Events

PETACH TIKVA, Israel–(BUSINESS WIRE)– Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have granted the Company a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent

Future Meat Technologies focuses on producing fat and muscle cells that are the core building blocks of meat, and is one of several firms working on technology to match rising demand for meat without adding more pressure on land from livestock.

MercuRemoval’s novel process for removing toxic mercury from flue-gas streams originated in the chemistry lab of Hebrew University professors Yoel Sasson and Zach Barnea. The company was established within Hutchison-Kinrot Cleantech seed incubator owned by Hutchison Water and was supported by Israel’s Innovation Authority R&D funds. It went commercial only three years later.

Israel's Technology Transfer Organization (ITTN) is pleased to announce its 4th professional conference, to be held on February 6th, 2017, at the David Intercontinental hotel in Tel Aviv.

This year, as we mark our 15th anniversary, we are excited to introduce a new format in which we will explore and aim to fuel the innovations and trends that are shaping the future of healthcare systems and life sciences. The conference will be divided into 9 tracks.
The Promise of Immuno-oncology, Neurological Disorders, Personalized Diagnostics and Precision Medicine, Listen to your Aching Heart, Health IT, Early Stage Challenges and Opportunities AND Start-up Competition, Robotics’ Role in Healthcare, The New “Kids” on the block (Microbiome, Gene Editing and Gene Therapy), From Academia Research to Industry.

The Israeli Academia Show Case Start-Up Competition, organized by ITTN, aims to recognize and endorse innovation that emerged from the Israeli academia and medical centers in the field of Life Sciences. It targets drug development, medical devices, diagnostic, therapeutic and e-health solutions.

Pearl Cohen, in collaboration with ITTN, are pleased to invite you to the third webinar session, on Open Source Governance. The webinar will be held on January 20, 15:00-16:00 IL time and will be conducted by Senior Partner Haim Ravia, Chair of Pearl Cohen's Internet, IT and Copyright Group and Senior Associate Dotan Hammer. Our upcoming webinar will explore Open Source Governance, discussing the value of an organizational policy for compliant use of FOSS and how supplemental use of automated FOSS management and governance tools can help streamline Open Source Governance.

We are delighted to announce the third annual conference of Israel’s Technology Transfer Organization (ITTN) to be held on December 10th, 2015 at the David Intercontinental hotel in Tel Aviv. The conference which is part of the Life Science Industry Event, is a joint effort of 15 technology transfer companies of the leading universities, hospitals and research institutes in Israel. ITTN 2015 will feature a main technology transfer track in addition to two parallel tracks focusing on hitech / engineering, pharma/biotech and agro. Building on the success of past conferences, we expect a diverse audience of over 300 participants from Blue Chip companies, VC`s, angel-investors, policy makers, technology transfer professionals, entrepreneurs and other.

Pearl Cohen, in collaboration with ITTN, are pleased to invite you to a series of webinar sessions on recent technology and legal matters. Join us on October 21 for the first webinar session on "Recent Changes in Patentability of Software Related Inventions" with Doron Sieradzki. This webinar will shed a light on the current status of what is and what is not patentable in the field of software invention, given the considerable changes the U.S Patent law has recently undergone.

ImmunArray Ltd announces the Launch of the SLE-key™ Rule Out test to be run out of VERACIS the Company’s Service Laboratory beginning in March 2015, in Richmond, Virginia